5. Mortality.
Study ID | Antibiotic class | Antibiotic | Antibotic frequency and amount | All‐cause mortality (n) | Total number of participants (N) | Duration of treatment |
Shafuddin 2015 | Macrolide + tetracycline | Roxithromycin + doxycycline | Continuous (300 mg + 100 mg daily) |
5 | 101 | 48 weeks follow‐up after 12 weeks active treatment (60 weeks) |
Shafuddin 2015 | Macrolide | Roxithromycin | Continuous (100 mg daily) | 3 | 97 | 48 weeks follow‐up after 12 weeks active treatment (60 weeks) |